Nanopath
Cambridge, Massachusetts, United States
Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. Nanopath aims to capture specific and actionable information that respects the nuance of the underlying biology. We envision Nanopath’s platform as the go-to system for routine women’s health screening at the point-of-care. Nanopath has developed deep technological breakthroughs that have the potential to change the molecular diagnostic paradigm. We aim to empower the patient and provider within the context of women’s most intimate infectious diseases and health obstacles.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- nanopath.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Nanopath?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now